BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16572927)

  • 1. Nicotine an efficient tool of the neurobiological research today, the tool of treatment tomorrow?
    Riljak V; Langmeier M
    Prague Med Rep; 2005; 106(4):329-48. PubMed ID: 16572927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine addiction: insights from recent animal studies.
    Mathieu-Kia AM; Kellogg SH; Butelman ER; Kreek MJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):102-18. PubMed ID: 12110988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
    Hogg RC; Bertrand D
    Biochem Pharmacol; 2007 Feb; 73(4):459-68. PubMed ID: 16979139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine: abused substance and therapeutic agent.
    Le Houezec J
    J Psychiatry Neurosci; 1998 Mar; 23(2):95-108. PubMed ID: 9549250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of phenoxybenzamine and nicotinic agonists at the nicotinic receptor in the cat adrenal medulla.
    Khan MT; Furchgott RF
    J Pharmacol Exp Ther; 1982 Apr; 221(1):117-22. PubMed ID: 7062277
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotinic receptor modulation for neuroprotection and enhancement of functional recovery following brain injury or disease.
    Pauly JR; Charriez CM; Guseva MV; Scheff SW
    Ann N Y Acad Sci; 2004 Dec; 1035():316-34. PubMed ID: 15681815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective and neurotoxic effects of nicotine.
    Ferrea S; Winterer G
    Pharmacopsychiatry; 2009 Nov; 42(6):255-65. PubMed ID: 19924585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.
    Egleton RD; Brown KC; Dasgupta P
    Pharmacol Ther; 2009 Feb; 121(2):205-23. PubMed ID: 19063919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat.
    Utsuki T; Shoaib M; Holloway HW; Ingram DK; Wallace WC; Haroutunian V; Sambamurti K; Lahiri DK; Greig NH
    J Alzheimers Dis; 2002 Oct; 4(5):405-15. PubMed ID: 12446972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action.
    Park HJ; Lee PH; Ahn YW; Choi YJ; Lee G; Lee DY; Chung ES; Jin BK
    Eur J Neurosci; 2007 Jul; 26(1):79-89. PubMed ID: 17581257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
    Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine: from molecular mechanisms to behaviour.
    Wonnacott S; Sidhpura N; Balfour DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):53-9. PubMed ID: 15661626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine: does it have a role in the treatment of skin disease?
    Ingram JR
    Postgrad Med J; 2009 Apr; 85(1002):196-201. PubMed ID: 19417169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do patients with schizophrenia smoke?
    Winterer G
    Curr Opin Psychiatry; 2010 Mar; 23(2):112-9. PubMed ID: 20051860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine and brain disorders.
    Mihailescu S; Drucker-Colín R
    Acta Pharmacol Sin; 2000 Feb; 21(2):97-104. PubMed ID: 11263271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective and antiamnesic effect of donepezil, a nicotinic acetylcholine-receptor activator, on rats with concussive mild traumatic brain injury.
    Fujiki M; Kubo T; Kamida T; Sugita K; Hikawa T; Abe T; Ishii K; Kobayashi H
    J Clin Neurosci; 2008 Jul; 15(7):791-6. PubMed ID: 18407501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional diversity of native brain neuronal nicotinic receptors.
    Gotti C; Clementi F; Fornari A; Gaimarri A; Guiducci S; Manfredi I; Moretti M; Pedrazzi P; Pucci L; Zoli M
    Biochem Pharmacol; 2009 Oct; 78(7):703-11. PubMed ID: 19481063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute intermittent nicotine treatment induces fibroblast growth factor-2 in the subventricular zone of the adult rat brain and enhances neuronal precursor cell proliferation.
    Mudò G; Belluardo N; Mauro A; Fuxe K
    Neuroscience; 2007 Mar; 145(2):470-83. PubMed ID: 17241745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal nicotinic receptor subtypes: defining therapeutic targets.
    Buccafusco JJ
    Mol Interv; 2004 Oct; 4(5):285-95. PubMed ID: 15471911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.